1. Yajie Li; Huaiyuan Huang; Jingwen Gao; Jinhong Lu; Guifeng Kang; Yipeng Ge; Wencan Jiang; Xiang Cai; Guojun Zhang; Lei Liu*, A TLK2-mediated calcium-driven cell death pathway links neuronal degeneration to nuclear envelope disruption, Nature Com munications , 2025, 16, 3419. 2. Gang Zhang*, Feng Wang, Shan Li , Kai-Wen Cheng , Yingying Zhu, Ran Huo, Elyar Abdukirim , Guifeng Kang*, Tsui-Fen Chou*, Discovery of small-molecule inhibitors of RUVBL1/2 ATPase, Bioorg. Med. Chem. , 2022, 62, 116726. 3. Boshi Huang, Huiqun Wang, Yi Zheng, Mengchu Li, Guifeng Kang, Victor Barreto-de-Souza, Nima Nassehi, Pamela E. Knapp, Dana E. Selley, Kurt F. Hauser, Yan Zhang*，Structure-Based Design and Development of Chemical Probes Targeting Putative MOR-CCR5 Heterodimers to Inhibit Opioid Exacerbated HIV-1 Infectivity， J. Med. Chem. , 2021, 64, 7702–7723. 4. Hongguang Ma, Huiqun Wang, Mengchu Li, Victor Barreto-de-Souza, Bethany A. Reinecke, Rama Gunta, Yi Zheng, Guifeng Kang, Nima Nassehi, Huijun Zhang, Jing An, Dana E. Selley, Kurt F. Hauser, Yan Zhang*， Bivalent Ligand Aiming Putative Mu Opioid Receptor and Chemokine Receptor CXCR4 Dimers in Opioid Enhanced HIV-1 Entry， ACS Med. Chem. Lett. , 2020, 11, 2318–2324. 5. Gui-Feng Kang*, Gang Zhang, One-pot synthesis of 1,3,5-triazine-2,4-dithione derivatives via three-component reactions, Beilstein J. Org. Chem. , 2020, 16, 1447–1455. 6. Bethany A. Reinecke, Guifeng Kang, Yi Zheng, Samuel Obeng, Huijun Zhang, Dana E. Selley, Jing An, Yan Zhang*, Design and synthesis of a bivalent probe targeting the putative mu opioid receptor and chemokine receptor CXCR4 heterodimer, RSC Med. Chem. , 2020, 11, 125-131. |
